All articles published in Cancer Drug Resistance (ISSN 2578-532X [Online]) are fully open access and are immediately and permanently available to read, download, and share worldwide upon publication.
The standard Article Processing Charge (APC) is USD 3,200. The APC supports the costs associated with editorial assessment, rigorous peer review, professional production services, online hosting, indexing support, and long-term digital preservation of published content. The APC is payable only after manuscript acceptance.
Eligible reviewers may receive reviewer vouchers that can be applied toward the APC of a subsequent article. Reviewer vouchers are subject to the applicable voucher terms and cannot be combined with other discounts or promotional offers.
There are no additional charges for article length, number of figures, color images, or supplementary materials.
For further information about publication fees, institutional agreements, and available discounts or waiver policies, please visit the OAE Publication Fees page.





